Proactive Investors USA & CanadaCell Therapeutics Announces European Launch Of Pixuvri® For Treatment Of …Sacramento BeeThe European Medicines Agency's (the "EMA") Committee for Medicinal Products for Human Use has accepted PIX306, CTI…
Researchers have enhanced agene therapy approach for children with adenosine deaminase-deficient severe combined immunodeficiency using chemotherapy as conditioning regimen. For the first time, investigators test two different viral vectors to transpor…
Gift of Life Transplant House in Rochester reports that its executive director is no longer with the organization. There is no interim director, and it's unclear whether a new director will be named. Vicki Allen
The West AustralianGM crop link to liver failureNew Zealand HeraldScientists have linked the risk of liver failure and death to wheat being genetically modified in Australian tests. The claims of New Zealand genetics lecturer Jack Heinemann and biochem…
2 Fundamental Reasons Why Bristol-Myers Squibb Is Outpacing Both Merck And …Seeking Alpha… SPRYCEL for treatment of chronic myeloid leukemia in adults; YERVOY to treat metastatic melanoma; ORENCIA to treat moderate to severe rheumatoid arthritis in…
MedPage TodayWARCEF: Warfarin protects against death/stroke in younger HF patientsTheHeart.OrgSeattle, WA – In a randomized trial that compared outcomes on warfarin vs aspirin in patients in sinus rhythm with systolic heart failure, those who were <…
3 injured in grenade blast in BongaigaonDaily News & Analysis"Three persons were injured when unidentified miscreants hurled a grenade near the Indian Oil Corporation point in the heart of Bongaigaon town," Assam's IGP (Law and Order) LR …
When her son, Colton, developed asthma-like symptoms and coughing at just a few months old, Jessica Ainslie, from Peoria, Ariz., took him to the doctor. Breathing treatments seemed to do the trick, but Colton was soon sick again — he developed thru…
Proactive Investors USA & CanadaCell Therapeutics shares surge on commercial launch of lymphoma drug in …Proactive Investors USA & CanadaThe company said it is also currently accruing patients into a phase 3 trial comparing pixantrone and rituximab w…
Elan unlikely target for Biogen given latter's focus on MS drug BG-12Financial TimesIn addition, the company is advancing daclizumab, an IL-2R antibody, in what will be the largest MS study ever conducted. Data is expected in 2014. On 13 August 201…